Bulletin
Investor Alert

Adial Pharmaceuticals Inc.

NAS: ADIL

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 3, 2023, 7:07 p.m.

/zigman2/quotes/203723380/composite

$

2.58

Change

-0.12 -4.44%

Volume

Volume 2

Quotes are delayed by 20 min

/zigman2/quotes/203723380/composite

Today's close

$ 2.66

$ 2.70

Change

+0.04 +1.50%

Day low

Day high

$2.68

$2.83

Open

52 week low

52 week high

$2.44

$15.00

Open

Insider Actions for Adial Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/23/2023 Cary J. Claiborne
Chief Executive Officer; Director
420,000   Award at $0 per share. 0
05/23/2023 William B. Stilley
Director
240,800   Award at $0 per share. 0
05/23/2023 Joseph Truluck
Chief Financial Officer
157,500   Award at $0 per share. 0
12/30/2022 William B. Stilley
Director
166,667   0
09/20/2022 Cary J. Claiborne
Chief Executive Officer; Director
75,000   Award at $0.42 per share. 31,500
09/19/2022 Cary J. Claiborne
Chief Executive Officer; Director
25,000   Award at $0.43 per share. 10,750
08/18/2022 Cary J. Claiborne
Chief Executive Officer; Director
1,000,000   Award at $0 per share. 0
02/23/2022 William B. Stilley
Director
250,000   Award at $0 per share. 0
12/30/2021 James W. Newman
Director
10,000   Acquisition at $2.71 per share. 27,100
12/30/2021 James W. Newman
Director
5,000   Acquisition at $2.72 per share. 13,600
12/30/2021 James W. Newman
Director
10,000   Acquisition at $2.66 per share. 26,600
12/23/2021 Kevin William Schuyler
Director
312,990   Gift at $0 per share. 0
11/30/2021 William B. Stilley
Director
10,600   Acquisition at $2.75 per share. 29,150
11/29/2021 William B. Stilley
Director
10,000   Acquisition at $2.59 per share. 25,900

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
3 Purchases
0 Sales
818,300
0
Last 12 months
3 Purchases
1 Sales
818,300
166,667

Officers and Executives

Mr. Cary J. Claiborne
Chief Operating Officer & Director
Mr. Joseph Truluck
Chief Financial Officer, Secretary & Treasurer
Dr. Julien Dimastromatteo
Vice President-Research
Dr. Bankole A. Johnson
Chief Medical Officer
Mr. Schuyler Vinzant
Vice President-Development
Mr. Mark H. Peikin
Chief Strategy Officer
Mr. Andrew E. Taubman
Vice President-Corporate Development
Mr. Alex Lugovoy
Chief Business Officer
Mr. William B. Stilley
President, Chief Executive Officer & Director
Ms. Catherine Fratila
Controller
Dr. Jack W. Reich
Head-Regulatory Affairs
Mr. John Rothwell Martin
Chief Legal Officer
Mr. Kevin William Schuyler
Vice Chairman
Mr. J. Kermit Anderson
Independent Director
Mr. Robertson H. Gilliland
Independent Director
Mr. James W. Newman
Independent Director
Mr. Tony Goodman
Independent Director
Link to MarketWatch's Slice.